Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 8051-8100 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT06570954
Retraining and Control Therapy (ReACT)- Adults
NARecruiting
50 participants
Started: Apr 10, 2025 · Completed: Dec 31, 2027
1 condition2 sponsors1 location
NCT06937554
Evaluation of Functional and Nutritional Parameters in Fit Acute Leukemia Patients
N/ARecruiting
30 participants
Started: Apr 10, 2025 · Completed: Sep 30, 2025
1 condition1 sponsor1 location
NCT06937112
18F Labeled FAP Targeted Molecular Probe in Early Tumor Diagnosis
N/ARecruiting
20 participants
Started: Apr 10, 2025 · Completed: Mar 31, 2026
4 conditions1 sponsor1 location
NCT06872996
Trophallergen Prick Tests (PT) : Influence of Food Sample Shelf Life on the Reproducibility of PT Results
NARecruiting
100 participants
Started: Apr 10, 2025 · Completed: Oct 10, 2027
1 condition1 sponsor1 location
NCT06992336
Circulating Tumor DNA Guided Boost Therapy in Early Triple Negative Breast Patients With Residual Disease After Neoadjuvant Therapy
PHASE2Recruiting
411 participants
Started: Apr 10, 2025 · Completed: Jan 1, 2036
1 condition1 sponsor1 location
NCT06947707
Safety and Efficacy of Edoxaban and Rivaroxaban to Cerebral Venous Thrombosis in Chinese Patients
N/ARecruiting
1,486 participants
Started: Apr 10, 2025 · Completed: Dec 31, 2027
9 conditions1 sponsor1 location
NCT06547463
Effects of Nasal Airflow on Sleep in Tracheotomized Patients
N/ARecruiting
24 participants
Started: Apr 10, 2025 · Completed: Apr 13, 2026
1 condition1 sponsor1 location
NCT06714617
Evaluate BL-M17D1 in Patients w/HER2-Expressing/Mutant Advanced or Metastatic Solid Tumors
PHASE1Recruiting
120 participants
Started: Apr 10, 2025 · Completed: Dec 1, 2027
14 conditions1 sponsor12 locations
NCT06898476
Silkworm Pupa Powder Improves Dementia.
NARecruiting
300 participants
Started: Apr 10, 2025 · Completed: Dec 31, 2026
3 conditions2 sponsors1 location
NCT06927284
Effects Of Neurocognitive Therapy With And Without Soft Robotic Hand On Hand Function
NARecruiting
46 participants
Started: Apr 10, 2025 · Completed: Oct 30, 2025
1 condition1 sponsor1 location
NCT07145697
The Electroencephalographic Mechanisms of Anesthesia and Human Consciousness
PHASE4Recruiting
30 participants
Started: Apr 10, 2025 · Completed: Jun 30, 2027
1 condition1 sponsor1 location
NCT06927362
LSVT Big and Dual Task Training in Cognitive Impaired Patients
NARecruiting
50 participants
Started: Apr 10, 2025 · Completed: Oct 30, 2025
4 conditions1 sponsor1 location
NCT06842316
Effects of Phytocannabinoids on Immune Response and Autophagy During Chronic Immune-mediated Inflammatory Diseases
N/ARecruiting
100 participants
Started: Apr 10, 2025 · Completed: Jan 25, 2026
7 conditions1 sponsor1 location
NCT06504160
Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2)
PHASE1/PHASE2Recruiting
86 participants
Started: Apr 10, 2025 · Completed: Nov 2, 2026
1 condition4 sponsors8 locations
NCT06931093
The Effectiveness of Group Guided Written Exposure Therapy for CPTSD Symptoms Among Adolescents
NARecruiting
120 participants
Started: Apr 10, 2025 · Completed: May 10, 2026
1 condition1 sponsor1 location
NCT06960460
Study Evaluating the Performance and Safety in the Medium and Long Term of Global D ZygoFixU System
NARecruiting
99 participants
Started: Apr 10, 2025 · Completed: Dec 31, 2031
1 condition1 sponsor3 locations
NCT06046586
Internet-Delivered Psychological Treatment for Cancer Survivors
NARecruiting
400 participants
Started: Apr 10, 2025 · Completed: Dec 31, 2031
3 conditions2 sponsors1 location
NCT06921512
TCM Daoyin for Anxiety/Depression: Psychological Effects and Biological Mechanisms
NARecruiting
20 participants
Started: Apr 10, 2025 · Completed: Sep 30, 2027
2 conditions2 sponsors1 location
NCT06868277
A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer
PHASE3Recruiting
830 participants
Started: Apr 10, 2025 · Completed: Dec 2, 2030
1 condition1 sponsor203 locations
NCT07025733
Semiconductor Embedded Socks for Ankle Sprains
NARecruiting
100 participants
Started: Apr 10, 2025 · Completed: Dec 31, 2026
1 condition3 sponsors1 location
NCT06830200
Peri-implantitis Treatment With Chitosan Brush
NARecruiting
60 participants
Started: Apr 10, 2025 · Completed: Jun 1, 2027
1 condition1 sponsor1 location
NCT06866054
Serratus Posterior Superior Intercostal Plane Block for Arthroscopic Shoulder Surgery
NARecruiting
50 participants
Started: Apr 10, 2025 · Completed: Aug 30, 2025
2 conditions1 sponsor2 locations
NCT06952049
Does Psychoeducation Improve the Pain Relief Derived From a Brief Intervention
NARecruiting
200 participants
Started: Apr 10, 2025 · Completed: Oct 31, 2025
2 conditions1 sponsor1 location
NCT04909970
Impact of a Self-hyPnOsis Practice on Chronic StresS Among Caregivers of Elderly People With Loss of Autonomy at Home
NARecruiting
60 participants
Started: Apr 10, 2025 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06308094
320-detector Computed Tomography to Assess Myocardial Extracellular Volume Fraction in Patients With Atrial Fibrillation Before AF Ablation.
NARecruiting
100 participants
Started: Apr 10, 2025 · Completed: Apr 1, 2026
1 condition2 sponsors1 location
NCT06547892
Use of Vasopressin in Patients at High Risk of Acute Kidney Injury Admitted to the ICU
PHASE2Recruiting
60 participants
Started: Apr 10, 2025 · Completed: Dec 10, 2025
1 condition1 sponsor1 location
NCT06887621
Efficacy of Adding Oral Amisulpride to Dual Prophylaxis for Postoperative Nausea and Vomiting in Patients at High Risk for Nausea and Vomiting Undergoing Gynecological Surgery
PHASE2Recruiting
276 participants
Started: Apr 10, 2025 · Completed: Mar 31, 2027
1 condition2 sponsors1 location
NCT07188311
Pucotenlimab Combined With Lenvatinib and Chemotherapy in the Treatment of Advanced, Relapsed/Refractory Hepatoblastoma in Children
NARecruiting
24 participants
Started: Apr 10, 2025 · Completed: Dec 10, 2027
2 conditions1 sponsor1 location
NCT06927206
Segmental Vibrator With NMES on Lower Limb Function in Subacute Stroke
NARecruiting
50 participants
Started: Apr 10, 2025 · Completed: Sep 30, 2025
2 conditions1 sponsor1 location
NCT07128823
Effects of Accelerated Skill Acquisition Programme With Segmental Vibration on Upper Limb in Stroke.
NARecruiting
60 participants
Started: Apr 10, 2025 · Completed: Oct 30, 2025
1 condition1 sponsor1 location
NCT06901791
Efficacy of Lactobacillus Rhamnosus LRa05 in Gestational Diabetes
NARecruiting
80 participants
Started: Apr 10, 2025 · Completed: Mar 10, 2026
1 condition1 sponsor1 location
NCT06647745
A Randomized, Double-blind, Multi-center, Active-controlled, Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of Combination Therapy of THP-00101, THP-00102, and THP-00103 in Subjects With T2DM and Essential Hypertension
PHASE3Recruiting
221 participants
Started: Apr 10, 2025 · Completed: Dec 1, 2026
2 conditions1 sponsor2 locations
NCT06929910
Assessing Systemic Treatment and ctDNA Monitoring Efficacy in Metastatic Cancer Patients Using K4Care Testing.
N/ARecruiting
200 participants
Started: Apr 9, 2025 · Completed: Jun 30, 2027
1 condition2 sponsors1 location
NCT06836947
The Effect of Two Different Bathing Methods on Vital Signs and Comfort in PICU:Bath Trial
N/ARecruiting
52 participants
Started: Apr 9, 2025 · Completed: May 30, 2025
2 conditions1 sponsor1 location
NCT06679374
Reducing Falls With Varenicline in Hypocholinergic Parkinson Disease
PHASE2Recruiting
102 participants
Started: Apr 9, 2025 · Completed: Jan 31, 2027
1 condition2 sponsors1 location
NCT06629766
The EPIC Study: Exploring Paternal Age and the Influence on Blastocyst Culture
NARecruiting
100 participants
Started: Apr 9, 2025 · Completed: Dec 31, 2026
5 conditions1 sponsor1 location
NCT06762002
Impaired Type I IFN Immunity Due to Autoantibodies or a Genetic Defect: a Prospective National Cohort
N/ARecruiting
500 participants
Started: Apr 9, 2025 · Completed: Jan 31, 2029
4 conditions1 sponsor9 locations
NCT06731270
Diclofenac for the Treatment of Patients With Metastatic Non-small Cell Lung Cancer on Single Agent Immunotherapy
PHASE2Recruiting
20 participants
Started: Apr 9, 2025 · Completed: Jan 1, 2027
4 conditions2 sponsors2 locations
NCT06580106
Toxicity Genetic Determinants and Response to Azacitidine and Venetoclax in AML
N/ARecruiting
50 participants
Started: Apr 9, 2025 · Completed: Jan 31, 2030
1 condition3 sponsors2 locations
NCT06907784
PRE-EMPTIVE PHARMACOGENOMICS IN ACUTE CARE SETTINGS WITH HEALTH ECONOMIC EVALUATIONS (PHOENIX TRIAL)
NARecruiting
2,000 participants
Started: Apr 9, 2025 · Completed: Sep 30, 2026
1 condition2 sponsors1 location
NCT06656702
Effects of Psilocybin in Patients With Amyotrophic Lateral Sclerosis
EARLY_PHASE1Recruiting
24 participants
Started: Apr 9, 2025 · Completed: Jul 1, 2026
1 condition2 sponsors1 location
NCT06694272
Functional and Anatomical Visual Investigations in Patients With Early Forms of Age-related Macular Degeneration
N/ARecruiting
120 participants
Started: Apr 9, 2025 · Completed: Apr 30, 2031
1 condition1 sponsor1 location
NCT07209306
WHO Psychological Interventions for Mental Health Outcomes in Migrants Resettled in Italy: the ADVANCE Trial
NARecruiting
237 participants
Started: Apr 9, 2025 · Completed: Apr 30, 2027
2 conditions2 sponsors1 location
NCT06556654
Tissue Reinforcement for Breast Reconstruction (TRBR) Pivotal Clinical Study (REDEFINE)
NARecruiting
180 participants
Started: Apr 9, 2025 · Completed: Jul 31, 2030
1 condition2 sponsors20 locations
NCT06904053
Metagenomics Next-generation Sequencing Approach to Detect Microbial DNA/RNA Overtime in Individuals Undergoing Hematopoietic Stem Cell Transplant
N/ARecruiting
30 participants
Started: Apr 9, 2025 · Completed: Dec 30, 2030
1 condition1 sponsor1 location
NCT06866275
Suramin for the Treatment of Autism Trial: KZ101 in a Male Pediatric Population With Autism Spectrum Disorder (ASD)
PHASE2Recruiting
45 participants
Started: Apr 9, 2025 · Completed: Apr 30, 2028
1 condition2 sponsors1 location
NCT06472622
Functional Neuroimaging to Detect the Neural Signatures of the Unpleasantness of Pain and Effort
EARLY_PHASE1Recruiting
47 participants
Started: Apr 9, 2025 · Completed: Jun 30, 2034
1 condition1 sponsor1 location
NCT06835530
A Combination of Rituximab and CC-99282 as Front-line Therapy for Older Frail Patients With Diffuse Large B-cells Non-Hodgkin Lymphoma Evaluated With a Simplified Geriatric Assessment (sGA): a Phase II Study of the Fondazione Italiana Linfomi (FIL)
PHASE2Recruiting
47 participants
Started: Apr 9, 2025 · Completed: Apr 30, 2030
1 condition1 sponsor19 locations
NCT06952413
Study of the Efficacy and Safety for Rituximab in Myalgia Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
PHASE2Recruiting
30 participants
Started: Apr 9, 2025 · Completed: Oct 31, 2027
1 condition1 sponsor1 location
NCT06793475
Aponermin-Based Bridging Therapy Prior to CAR-T Infusion in Relapsed/Refractory Multiple Myeloma Patients With Extramedullary Disease
NARecruiting
20 participants
Started: Apr 9, 2025 · Completed: Dec 31, 2026
1 condition1 sponsor2 locations